SCHEMBL3281948

SCHEMBL3281948

Cc1[nH]c(C(=O)NC2CCN(c3nc(CNS(C)(=O)=O)c(C(=O)O)s3)CC2)c(Cl)c1Cl

nearest known ligand 0.59

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ABCC2 Q92887 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3281310 0.88 ABCC2 (0.57) ABCC2
SCHEMBL3280877 0.88 ABCC2 (0.54) ABCC2
SCHEMBL3288453 0.87 ABCC2 (0.52) ABCC2
SCHEMBL3282145 0.86 ABCC2 (0.52) ABCC2
SCHEMBL3285025 0.86 ABCC2 (0.58) ABCC2
SCHEMBL3284262 0.86 ABCC2 (0.51) ABCC2
SCHEMBL3281497 0.85 ABCC2 (0.52) ABCC2
SCHEMBL3288213 0.85 ABCC2 (0.51) ABCC2
SCHEMBL3289159 0.84 ABCC2 (0.53) ABCC2
SCHEMBL3280848 0.84 ABCC2 (0.55) ABCC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7709503-B2 Pyrrol derivatives with antibacterial activity ASTRAZENECA AB (SE) 2010-05-04 US disclosed
EP-1664025-B1 PYRROL DERIVATIVES WITH ANTIBACTERIAL ACTIVITY ASTRAZENECA AB (SE) 2007-09-19 EP disclosed
US-20060223801-A1 Pyrrol derivatives with antibacterial activity ASTRAZENECA AB (SE) 2006-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060223801-A1 Pyrrol derivatives with antibacterial activity PEF1, PEPD, PELP1 ABCC2 4119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.